Centessa Pharmaceuticals Plc (CNTA)
39.76
+0.08
(+0.19%)
USD |
NASDAQ |
Jun 11, 16:00
39.76
0.00 (0.00%)
After-Hours: 20:00
Centessa Pharmaceuticals Shareholders Equity (Quarterly) : 487.35M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 487.35M |
| December 31, 2025 | 526.86M |
| September 30, 2025 | 301.57M |
| June 30, 2025 | 344.92M |
| March 31, 2025 | 386.25M |
| December 31, 2024 | 401.54M |
| September 30, 2024 | 499.14M |
| June 30, 2024 | 286.96M |
| March 31, 2024 | 215.16M |
| December 31, 2023 | 236.24M |
| September 30, 2023 | 259.39M |
| Date | Value |
|---|---|
| June 30, 2023 | 276.61M |
| March 31, 2023 | 293.26M |
| December 31, 2022 | 336.17M |
| September 30, 2022 | 372.92M |
| June 30, 2022 | 420.04M |
| March 31, 2022 | 480.15M |
| December 31, 2021 | 491.55M |
| September 30, 2021 | 549.13M |
| June 30, 2021 | 585.64M |
| March 31, 2021 | 278.63M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Biogen, Inc. | 18.65B |
| Roivant Sciences Ltd. | 4.527B |
| Eli Lilly & Co. | 31.20B |
| Aptorum Group Ltd. | 23.12M |
| Bicycle Therapeutics Plc | 554.32M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 641.76M |
| Total Liabilities (Quarterly) | 154.42M |
| Debt to Equity Ratio | 0.2433 |
| Current Ratio | 9.534 |
| Net Debt Paydown Yield | -0.00% |